About
Alok Sonig served as Executive Vice President and Group President, Pharmaceuticals of Baxter International. On November 5, 2025, he notified the company of his decision to resign from that role, effective December 1, 2025, to join a company in the healthcare industry.
Roles
Baxter International Inc.
Executive Vice President & Group President, Pharmaceuticals · Current role
Present
Baxter International Inc.
Executive Vice President and Group President, Pharmaceuticals · Notified the company of his resignation on November 5, 2025.
until December 1, 2025
Lupin, Inc.
US CEO and Global Head of R&D and Biosimilars
—
Dr. Reddy's Laboratories
CEO of Developed Markets
—
Bristol Myers Squibb
General management, global strategy and marketing roles
15+ years
Fixed Compensation
FY 2025
All other compensation
$19,577
Total compensation
$5,239,273
Performance Compensation
Data from FY 2025
Stock awards
Also at Baxter International Inc.